The MC Roundtable: how CDMO’s are responding to pharma’s top priorities in 2021 (part 1)
March 19, 2021
The drug manufacturing industry is increasingly enlisting outsourcing partners like CDMOs to address a broad range of megatrends which is making the current commercial realities of early stage drug development and manufacturing all the more complex.
In this roundtable with Manufacturing Chemist, Lynn Allen, MedPharm’s Vice President of Business Development, explores the most important aspects to consider in order to meet customer demands for both flexibility and operational excellence.
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm is experts at reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through their unique, cost-effective and industry-leading performance testing models. Well established as the global leaders in dermatology, nail, mucosal membrane, and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognised for their scientific rigour by regulators and investors. MedPharm has fully established Centers of Excellence in the USA and the UK.